K2M will celebrate the opening of its new Leesburg headquarters this afternoon, but that is not the only good news for the global medical device company.
The FDA recently awarded clearances for the company to move forward with the use of 3D printing technology in the development of its titanium devices that aid patients with degenerative disc disease and degenerative scoliosis.
K2M’s system uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques,” according to an explanation in the company’s website. “Starting with a titanium powder, the implants are grown through the selective application of a high-energy laser beam, allowing for the incorporation of both a porosity and surface roughness that pre-clinical data have associated with bone growth activity.”
K2M is the first major spine company to introduce a 3D-printed titanium “interbody device,” advancing its mission to become the world leader for complex spinal solutions.